Health Care · Biotechnology
Clarity Pharmaceuticals: Products & infrastructure
Clarity Pharmaceuticals has 11 clinical trials on record, 3 under way.
Data updated Nov 22, 2026 · Back to the company report
Products
Clarity Pharmaceuticals has 11 clinical trials on record, 3 under way.
11clinical trials
3trials under way
2in phase 3
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 3 more records
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate …
phase 3 · under way · 220 participants · Prostate Cancer; Prostate Cancer Patients With Detectable PSA Following Prostat…
May 2025
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Pro…
phase 3 · under way · 383 participants · Prostate Cancer; Prostatic Neoplasms
Dec 2023
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing …
phase 2 · stopped or withdrawn · 4 participants · Prostatic Neoplasms; Castration-Resistant
Jun 2023
64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)
phase 2 · completed · 53 participants · Biochemical Recurrence of Malignant Neoplasm of Prostate
Sep 2022
64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)
phase 2 · completed · 52 participants · Biochemical Recurrence of Malignant Neoplasm of Prostate
Apr 2022
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant…
phase 2 · under way · 54 participants · Prostatic Neoplasms, Castration-Resistant
Aug 2021
Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPE…
phase 1 · completed · 30 participants · Prostatic Neoplasms
Jul 2021
A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)
phase 2 · completed · 45 participants · Neuroendocrine Tumors
Mar 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
